Featured
-
-
Correspondence |
Comment on “Redefining cancer research for therapeutic breakthroughs”
- Prasad Cooray
-
Article |
Extending the dosing intervals of nivolumab: model-based simulations in unselected cancer patients
- Alicja Puszkiel
- , Guillaume Bianconi
- & Benoit Blanchet
-
Article
| Open Access
Combination of EZH2 and ATM inhibition in BAP1-deficient mesothelioma
- Nick Landman
- , Danielle Hulsman
- & Maarten van Lohuizen
-
Article |
Association of immune-related adverse events with durvalumab efficacy after chemoradiotherapy in patients with unresectable Stage III non-small cell lung cancer
- Koji Haratani
- , Atsushi Nakamura
- & Hidetoshi Hayashi
-
Perspective |
Radiation therapy with phenotypic medicine: towards N-of-1 personalization
- Li Ming Chong
- , Peter Wang
- & Dean Ho
-
Article
| Open Access
Cannabinoids induce cell death in leukaemic cells through Parthanatos and PARP-related metabolic disruptions
- M. Medrano
- , M. Contreras
- & J. A. Pérez-Simón
-
Perspective
| Open Access
Redefining cancer research for therapeutic breakthroughs
- Arseniy E. Yuzhalin
-
Article
| Open Access
Solar ultraviolet radiation exposure, and incidence of childhood acute lymphocytic leukaemia and non-Hodgkin lymphoma in a US population-based dataset
- Mark P. Little
- , Jim Z. Mai
- & Michael G. Kimlin
-
Article
| Open Access
Risk of cancer and serious disease in Danish patients with urgent referral for serious non-specific symptoms and signs of cancer in Funen 2014–2021
- Rasmus Birkholm Grønnemose
- , Per Syrak Hansen
- & Peter Thye-Rønn
-
Article
| Open Access
Fluoropyrimidine type, patient age, tumour sidedness and mutation status as determinants of benefit in patients with metastatic colorectal cancer treated with EGFR monoclonal antibodies: individual patient data pooled analysis of randomised trials from the ARCAD database
- C. S. Karapetis
- , H. Liu
- & Q. Shi
-
Article
| Open Access
CAnceR IN PreGnancy (CARING) – a retrospective study of cancer diagnosed during pregnancy in the United Kingdom
- M. A. Baxter
- , M. Denholm
- & J. Harris
-
Article |
ABCC4 suppresses glioblastoma progression and recurrence by restraining cGMP-PKG signalling
- Jung-Ying Chiang
- , Sung-Tai Wei
- & Chia-Hung Hsieh
-
Article |
IL-24 improves efficacy of CAR-T cell therapy by targeting stemness of tumor cells
- Kai Zhang
- , Wenhao Hu
- & Yi Zhang
-
Article |
Late endocrine diseases in survivors of adolescent and young adult cancer in California: a population-based study
- Renata Abrahão
- , Ann Brunson
- & Theresa H. M. Keegan
-
Article
| Open Access
A UK prospective multicentre decision impact, decision conflict and economic evaluation of the 21-gene assay in women with node+ve, hormone receptor+ve, HER2-ve breast cancer
- Simon Holt
- , Mark Verrill
- & Saira Khawaja
-
Article
| Open Access
Risk of subsequent gliomas and meningiomas among 69,460 5-year survivors of childhood and adolescent cancer in Europe: the PanCareSurFup study
- Emma J. Heymer
- , Michael M. Hawkins
- & Raoul C. Reulen
-
Article |
Minimum latency effects for cancer associated with exposures to radiation or other carcinogens
- Mark P. Little
- , Markus Eidemüller
- & A. Iulian Apostoaei
-
Article
| Open Access
The impact of circulating protein levels identified by affinity proteomics on short-term, overall breast cancer risk
- Felix Grassmann
- , Anders Mälarstig
- & Kamila Czene
-
Article |
Factors associated with the melanoma diagnostic interval in Ontario, Canada: a population-based study
- Meaghan E. Mavor
- , Timothy P. Hanna
- & Patti A. Groome
-
Article |
Treatment interval in curative treatment of colon cancer, does it impact (cancer free) survival? A non-inferiority analysis
- Maud T. A. Strous
- , Charlotte J. L. Molenaar
- & F. Jeroen Vogelaar
-
Article
| Open AccessEpithelial ovarian cancer survival by race and ethnicity in an equal-access healthcare population
- Zhaohui L. Arter
- , Daniel Desmond
- & Melissa A. Merritt
-
Article |
Fatal and non-fatal breast cancers in women targeted by BreastScreen Norway: a cohort study
- Kaitlyn M. Tsuruda
- , Solveig Roth Hoff
- & Solveig Hofvind
-
Article |
Downregulation of N4-acetylcytidine modification in myeloid cells attenuates immunotherapy and exacerbates hepatocellular carcinoma progression
- Nan Xu
- , Jianyong Zhuo
- & Qiang Wei
-
Review Article
| Open Access
Unlocking hidden potential: advancements, approaches, and obstacles in repurposing drugs for cancer therapy
- Freya R. Weth
- , Georgia B. Hoggarth
- & Clint Gray
-
Article |
Long-term outcomes of neoadjuvant immunotherapy plus chemotherapy in patients with early-stage triple-negative breast cancer: an extracted individual patient data and trial-level meta-analysis
- Mateus Trinconi Cunha
- , Mariana Carvalho Gouveia
- & Renata Colombo Bonadio
-
Article
| Open Access
Apalutamide efficacy, safety and wellbeing in older patients with advanced prostate cancer from Phase 3 randomised clinical studies TITAN and SPARTAN
- John Shen
- , Simon Chowdhury
- & Julie N. Graff
-
Article
| Open Access
Breast cancers with high proliferation and low ER-related signalling have poor prognosis and unique molecular features with implications for therapy
- Luca Licata
- , Marco Barreca
- & Giampaolo Bianchini
-
Article |
Radiomics-based decision support tool assists radiologists in small lung nodule classification and improves lung cancer early diagnosis
- Benjamin Hunter
- , Christos Argyros
- & Anand Devaraj
-
Article
| Open Access
Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic ductal adenocarcinoma having high serum eotaxin levels (KG4/2015): an open-label, randomised, Phase 3 trial
- Jung Hyun Jo
- , Yong-Tae Kim
- & Si Young Song
-
Review Article
| Open Access
Body composition and cancer survival: a narrative review
- Patrick T. Bradshaw
-
Article
| Open Access
Personalised lung cancer risk stratification and lung cancer screening: do general practice electronic medical records have a role?
- Bhautesh Dinesh Jani
- , Michael K. Sullivan
- & Frank M. Sullivan
-
Article
| Open Access
Phase II study of everolimus and temozolomide as first-line treatment in metastatic high-grade gastroenteropancreatic neuroendocrine neoplasms
- Siren Morken
- , Seppo W. Langer
- & Halfdan Sorbye
-
Article
| Open Access
Generation of evidence-based carboplatin dosing guidelines for neonates and infants
- Shelby Barnett
- , Guy Makin
- & Gareth J. Veal
-
Article
| Open Access
Outcomes of relapsed clinical stage I versus de novo metastatic testicular cancer patients: an analysis of the IGCCCG Update database
- Jakob Lauritsen
- , Nicolas Sauvé
- & Gedske Daugaard
-
Article |
Vitamin C intake and colorectal cancer survival according to KRAS and BRAF mutation: a prospective study in two US cohorts
- Shanshan Shi
- , Kai Wang
- & Mingyang Song
-
Article |
Biopsy-free AI-aided precision MRI assessment in prediction of prostate cancer biochemical recurrence
- Ying Hou
- , Ke-Wen Jiang
- & Yu-Dong Zhang
-
Article
| Open Access
Inequalities in treatment among patients with colon and rectal cancer: a multistate survival model using data from England national cancer registry 2012–2016
- Suping Ling
- , Miguel-Angel Luque Fernandez
- & Bernard Rachet
-
Article
| Open Access
Evidence into practice: a national cohort study of NICE-recommended oncological drug therapy utilisation among women diagnosed with invasive breast cancer in England
- Melissa Ruth Gannon
- , David Dodwell
- & David Alan Cromwell
-
Article
| Open Access
Differential response of HER2-positive breast cancer to anti-HER2 therapy based on HER2 protein expression level
- N. M. Atallah
- , M. Alsaleem
- & E. Rakha
-
Article
| Open Access
A first-in-human phase 1 study of nofazinlimab, an anti-PD-1 antibody, in advanced solid tumors and in combination with regorafenib in metastatic colorectal cancer
- Daphne Day
- , John J. Park
- & Archie N. Tse
-
Perspective
| Open AccessEvaluating multi-cancer early detection tests: an argument for the outcome of recurrence-updated stage
- Matthew E. J. Callister
- , Emma J. Crosbie
- & Hilary A. Robbins
-
Article
| Open Access
Years of life lost due to cancer in the United Kingdom from 1988 to 2017
- Amar S. Ahmad
- , Judith Offman
- & Peter D. Sasieni
-
Article
| Open Access
A spectroscopic liquid biopsy for the earlier detection of multiple cancer types
- James M. Cameron
- , Alexandra Sala
- & Matthew J. Baker
-
Article |
BEX1 supports the stemness of hepatoblastoma by facilitating Warburg effect in a PPARγ/PDK1 dependent manner
- Qian Wang
- , Ning Liang
- & Gang Wang
-
Article
| Open Access
Exposure to low-level ambient air pollution and the relationship with lung and bladder cancer in older men, in Perth, Western Australia
- Elizabeth H. Lim
- , Peter Franklin
- & Jane Heyworth
-
Article
| Open Access
Axitinib in patients with advanced/metastatic soft tissue sarcoma (Axi-STS): an open-label, multicentre, phase II trial in four histological strata
- Penella J. Woll
- , Piers Gaunt
- & Lucinda Billingham
-
Article
| Open Access
Targeting hyaluronan-mediated motility receptor (HMMR) enhances response to androgen receptor signalling inhibitors in prostate cancer
- Josephine A. Hinneh
- , Joanna L. Gillis
- & Lisa M. Butler
-
Article |
Effect of a 1-year physical activity intervention on cardiovascular health in long-term childhood cancer survivors—a randomised controlled trial (SURfit)
- Corina S. Rueegg
- , Simeon J. Zürcher
- & Susi Kriemler
-
Article
| Open Access
Ex vivo drug sensitivity screening predicts response to temozolomide in glioblastoma patients and identifies candidate biomarkers
- Ioannis Ntafoulis
- , Anne Kleijn
- & Martine L. M. Lamfers
Predicting the risk of pancreatic cancer in adults with new-onset diabetes: development and internal–external validation of a clinical risk prediction model